Mechanism of cell infection with hepatitis C virus (HCV) - A new paradigm in virus-cell interaction

Polish Journal of Microbiology

Volumn 58, Issue 2, 2009, Pages 93-98

  Budkowska, Agata ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Cellular receptors; Hepatitis C virus; Lipoproteins; Mirotubules; Virus entry

Indexed keywords

CD81 ANTIGEN; CLAUDIN 1; HEPARAN SULFATE; LOW DENSITY LIPOPROTEIN RECEPTOR; NUCLEOCAPSID PROTEIN; OCCLUDIN; SCAVENGER RECEPTOR BI; VERY LOW DENSITY LIPOPROTEIN;

CELL CYCLE; FATTY LIVER; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; SHORT SURVEY; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS PARTICLE;

ANTIVIRAL AGENTS; HEPACIVIRUS; HEPATITIS C; HUMANS; RECEPTORS, CELL SURFACE;

FLAVIVIRIDAE; HEPATITIS C VIRUS; RNA VIRUSES;

EID: 69549088817     PISSN: 17331331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (72)

1. Agnello V., G. Abel, M. Elfahal, G.B. Knight, and Q.X. Zhang. 1999. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Nat. Acad. Sci. USA 96: 12766-12771.
2. André P., F. Komurian-Pradel, S. Deforges, M. Perret, J.L. Berland, M. Sodoyer, S. Pol, C. Brechot, G. Paranhos-Baccala and V. Lotteau. 2002. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J. Virol. 76: 6919-6928.
3. André P., G. Perlemuter, A. Budkowska, C. Brechot and V. Lotteau. 2005. Hepatitis C virus particles and lipoprotein metabolism. Sem. Liver Dis. 25: 93-104.
4. Andréo U., P. Maillard, O. Kalinina, M. Walic, E. Meurs, M. Martinot, P. Marcellin and A. Budkowska. 2007. Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection. Cell Microbiol. 9: 2445-2456. (Pubitemid 47365649)
5. Barba G., F. Harper, T. Harada, M. Kohara, S. Goulinet, Y. Matsuura, G. Eder, Z. Schaff, M. J. Chapman, T. Miyamura and C. Brechot. 1997. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc. Nat. Acad. Sci. USA 94: 1200-1205.
6. Bartenschlager, R., M. Frese and T. Pietschmann. 2004. Novel insights into hepatitis C virus replication and persistence. Adv. Virus Res. 63: 71-180.
7. Barth H., C. Schafer, M.I. Adah, F. Zhang, R.J. Linhardt, H. Toyoda, A. Kinoshita-Toyoda, T. Toida, T.H. van Kuppevelt, E. Depla, F. von Weizsacker, H.E. Blum and T.F. Baumert. 2003. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J. Biol. Chem. 278: 41003-41012.
8. Bartosch B., J. Dubuisson and F.L. Cosset. 2003. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 197: 633-642.
9. Bartosch B., G. Verney, M. Dreux, P. Donot, Y. Morice, F. Penin, J.-M. Pawlotsky, D. Lavillette and F.-L. Cosset. 2005. An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against Neutralizing Antibodies. J. Virol. 79: 8217-8229. (Pubitemid 40853525)
10. Blanchard E., S. Belouzard, L. Goueslain, T. Wakita, J. Dubuisson, C. Wychowski and Y. Rouille. 2006. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J. Virol. 80: 6964-6972. (Pubitemid 44025195)
11. Boulant S., M.W. Douglas, L. Moody, A. Budkowska, P. Targett-Adams and J. McLauchlan. 2008. Hepatitis C virus core protein induces lipid droplet redistribution in a microtubule-and dynein-dependent manner. Traffic. 9: 1268-1282. (Pubitemid 352016286)
12. Boulant S., P. Targett-Adams and J. McLauchlan. 2007. Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus. J. Gen. Virol. 88: 2204-2213.
13. Bradley D., K. McCaustland, K. Krawczynski, J. Spelbring, C. Humphrey and E.H. Cook. 1991. Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose. J. Med. Virol. 34: 206-208.
14. Brass V., D. Moradpour and H.E. Blum. 2006. Molecular virology of hepatitis C virus (HCV): 2006 update. Int. J. Med. Sci. 3: 29-34.
15. Brazzoli M., A. Bianchi, S. Filippini, A. Weiner, Q. Zhu, M. Pizza and S. Crotta. 2008. CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes. J. Virol. 82: 8316-8329.
16. Bukh J. and R.H. Purcell. 2006. A milestone for hepatitis C virus research: A virus generated in cell culture is fully viable in vivo. Proc. Natl. Acad. Sci. USA 103: 3500-3501.
17. Burlone M.E. and A. Budkowska. 2009. Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. J. Gen. Virol. 90: 1055-1070.
18. Chang K.S., J. Jiang, Z. Cai and G. Luo. 2007. Human apolipoprotein E is required for infectivity and production of hepatitis C virus in cell culture. J. Virol. 81: 13783-13793.
19. Coyne C.B., L. Shen, J.R. Turner and J.M. Bergelson. 2007. Coxsackievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5. Cell. Host. Microb. 2: 181-192.
20. Diaz O., F. Delers, M. Maynard, S. Demignot, F. Zoulim, J. Chambaz, C. Trepo, V. Lotteau and P. André. 2006. Preferential association of hepatitis C virus with apolipoprotein B48-containing lipoproteins. J. Gen. Virol. 87: 2983-2991.
21. Dreux M., B. Boson, S. Ricard-Blum, J. Molle, D. Lavillette, B. Bartosch, E.I. Pecheur and F.L. Cosset. 2007. The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus. J. Biol. Chem. 282: 32357-32369.
22. Evans M.J., T. von Hahn, D.M. Tscherne, A.J. Syder, M. Panis, B. Wolk, T. Hatziioannou, J.A. McKeating, P.D. Bieniasz and C.M. Rice. 2007. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446: 801-805. (Pubitemid 46582027)
23. Gale M., Jr. and E.M. Foy. 2005. Evasion of intracellular host defence by hepatitis C virus. Nature 436: 939-945 (Pubitemid 41191669)
24. Gastaminza P., G. Cheng, S. Wieland, J. Zhong, W. Liao and F.V. Chisari. 2008. Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J. Virol. 82: 2120-2129. (Pubitemid 351293514)
25. Gosert R., D. Egger, V. Lehmann, R. Bartenschlager, H.E. Blum, K. Bienz and D. Moradpour. 2003. Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harbouring subgenomic replicons. J. Virol. 77: 5487-5492. (Pubitemid 36460961)
26. Haberstroh A., E.K. Schnober, M.B. Zeisel, P. Carolla, H. Barth, H.E. Blum, F.L. Cosset, G. Koutsoudakis, R. Bartenschlager, A. Union, E. Depla, A. Owsianka, A.H. Patel, C. Schuster, F. Stoll-Keller, M. Doffoel, M. Dreux and T.F. Baumert. 2008. Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion. Gastroenterology 135: 1719-1728.
27. Helle F., C. Wychowski, N. Vu-Dac, K.R. Gustafson, C. Voisset and J. Dubuisson. 2006. Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans. J. Biol. Chem. 281: 25177-25183.
28. Huang H., F. Sun, D.M. Owen, W. Li, Y. Chen, M. Gale, Jr. and J. Ye. 2007. Hepatitis C virus production by human hepatocytes is dependent on assembly and secretion of very low-density lipoproteins. Proc. Natl. Acad. Sci. USA 104: 5848-5853.
29. Jones D.M., S.N. Gretton, J. McLauchlan and P. Targett-Adams. 2007. Mobility analysis of an NS5A-GFP fusion protein in cells actively replicating hepatitis C virus subgenomic RNA. J. Gen. Virol. 88: 470-475.
30. Kapadia S.B. and F.V. Chisari. 2005. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc. Natl. Acad. Sci. USA 102: 2561-2566.
31. Keam S.J. and R.S. Cvetkovic. 2008. Peginterferon-alpha-2a (40 kD) plus ribavirin: a review of its use in the management of chronic hepatitis C mono-infection. Drugs 68: 1273-1317.
32. Koutsoudakis G., A. Kaul, E. Steinmann, S. Kallis, V. Lohmann, T. Pietschmann and R. Bartenschlager. 2006. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J. Virol. 80: 5308-5320.
33. Lai C.K., K.S. Jeng, K. Machida and M.M. Lai. 2008. Association of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A. J. Virol. 82: 8838-8848.
34. Lanford R.E., M.J. Evans, V. Lehmann, B. Lindenbach, M. Gale, Jr., B. Rehermann, K.M. Chang and S.M. Lemon. 2009. The accelerating pace of HCV research: a summary of the 15th International Symposium on Hepatitis C Virus And Related Viruses. Gastroenterology 136: 9-16.
35. Lavillette D., E.I. Pecheur, P. Donot, J. Fresquet, J. Molle, R. Corbau, M. Dreux, F. Penin and F.L. Cosset. 2007. Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. J. Virol. 81: 8752-8765. (Pubitemid 47242848)
36. Lindenbach B.D., M.J. Evans, A.J. Syder, B. Wolk, T.L. Tellinghuisen, C.C. Liu, T. Maruyama, R.O. Hynes, D.R. Burton, J.A. McKeating and C.M. Rice. 2005. Complete replication of hepatitis C virus in cell culture. Science 309: 623-626.
37. Lindenbach B.D., P. Meuleman, A. Ploss, T. Vanwolleghem, A.J. Syder, J.A. McKeating, R.E. Lanford, S.M. Feinstone, M.E. Major, G. Leroux-Roels and C.M. Rice. 2006. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc. Natl. Acad. Sci. USA 103: 3805-3809.
38. Liu S., W. Yang, L. Shen, J.R. Turner, C.B. Coyne and T. Wang. 2008. Tight junction proteins Claudin-1 and occludin control hepatitis C virus entry and are down-regulated during infection to prevent superinfection. J. Virol. 83: 2011-2014
39. Maillard P., T. Huby, U. Andréo, M. Moreau, J. Chapman and A. Budkowska. 2006. The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins. FASEB J. 20: 735-737. (Pubitemid 46671198)
40. Maillard P., K. Krawczynski, J. Nitkiewicz, C. Bronnert, M. Sidorkiewicz, P. Gounon, J. Dubuisson, G. Faure, R. Crainic and A. Budkowska. 2001. Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J. Virol. 75: 8240-8250. (Pubitemid 32743696)
41. Maillard P., J.P. Lavergne, S. Siberil, G. Faure, F. Roohvand, S. Petres, J.L. Teillaud and A. Budkowska. 2004. Fcgamma receptor-like activity of hepatitis C virus core protein. J. Biol. Chem. 279: 2430-2437.
42. Masciopinto F., C. Giovani, S. Campagnoli, L. Galli-Stampino, P. Colombatto, M. Brunetto, T.S. Yen, M. Houghton, P. Pileri and S. Abrignani. 2004. Association of hepatitis C virus envelope proteins with exosomes. Eur. J. Immunol. 34: 2834-2842.
43. Meertens L., C. Bertaux and T. Dragic. 2006. Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. J. Virol. 80: 11571-11578. (Pubitemid 44788871)
44. Meunier J.-C., R.E. Engle, K. Faulk, M. Zhao, B. Bartosch, H. Alter, S.U. Emerson, F.-L. Cosset, R.H. Purcell and J. Bukh. 2005. Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc. Natl. Acad. Sci. USA 102: 4560-4565.
45. Meurs E.F. and A. Breiman. 2007. The interferon inducing pathways and the hepatitis C virus. World J. Gastroenterol. 7: 2446-2454.
46. Miyanari Y., K. Atsuzawa, N. Usuda, K. Watashi, T. Hishiki, M. Zayas, R. Bartenschlager, T. Wakita, M. Hijikata and K. Shimotohno. 2007. The lipid droplet is an important organelle for hepatitis C virus production. Nature Cell. Biol. 9: 1089-1097.
47. Molina S., D. Missé, S. Roche, S. Badiou, J.P. Cristol, C. Bonfils, J.F. Dierick, F. Veas, T. Levayer, D. Bonnefont-Rousselot, P. Maurel, J. Coste and C. Fournier-With. 2008. Identification of ApoC-III as a potential plasmatic biomarker associated with the resolution of HCV infection. Proteomics Clin. Appl. 2: 751-761.
48. Monazahian M., I. Bohme, S. Bonk, A. Koch, C. Scholz, S. Grethe and R. Thomssen. 1999. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J. Med. Virol. 57: 223-229.
49. Nielsen S.U., M.F. Bassendine, A.D. Burt, C. Martin, W. Pumeechockchai and G.L. Toms. 2006. Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J. Virol. 80: 2418-2428.
50. Pawlotsky J.M. 2006. Therapy of hepatitis C: from empiricism to eradication. Hepatology 43: S207-220.
51. Penin F., J. Dubuisson, F.A. Rey, D. Moradpour and J.M. Pawlotsky. 2004. Structural biology of hepatitis C virus. Hepatology 39: 5-19.
52. Petit J.M., M. Benichou, L. Duvillard, V. Jooste, J.B. Bour, A. Minello, B. Verges, J.M. Brun, P. Gambert and P. Hillon. 2003. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis. Am. J. Gastroenterol. 98: 1150-1154.
53. Petit M.A., M. Lievre, S. Peyrol, S. De Sequeira, P. Berthillon, R. W. Ruigrok and C. Trepo. 2005. Enveloped particles in the serum of chronic hepatitis C patients. Virology 336: 144-153. (Pubitemid 40693949)
54. Pietschmann T. 2009. Virology: Final entry key for hepatitis C. Nature 457: 797-798.
55. Pileri P., Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A.J. Weiner, M. Houghton, D. Rosa, G. Grandi and S. Abrignani. 1998. Binding of hepatitis C virus to CD81. Science 282: 938-941.
56. Ploss A., M.J. Evans, V.A. Gaysinskaya, M. Panis, H. You, Y.P. de Jong and C.M. Rice. 2009. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457: 882-886.
57. Radtke K., K. Dohner and B. Sodeik. 2006. Viral interactions with the cytoskeleton: a hitchhiker's guide to the cell. Cell. Microbiol. 8: 387-400.
58. Rehermann B. and M. Nascimbeni. 2005. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5: 215-229.
59. Rocha-Perugini V., C. Montpellier, D. Delgrange, C. Wychowski, F. Helle, A. Pillez, H. Drobecq, F. Le Naour, S. Charrin, S. Levy, E. Rubinstein, J. Dubuisson and L. Cocquerel. 2008. The CD81 partner EWI-2wint inhibits hepatitis C virus entry. PLoS ONE 3: e1866.
60. Rodinov V.I. and G.G. Borisy. 1997. Microtubules treadmilling in vivo. Science 275: 215-218
61. Roohvand F., P. Maillard, J.P. Lavergne, S. Boulant, M. Walic, U. Andréo, L. Goueslain, F. Helle, A. Mallet, J. McLauchlan and A. Budkowska. 2009. Initiation of hepatitis C virus infection requires the dynamic microtubule network: Role of the viral nucleocapsid protein. J. Biol. Chem. 284: 13778-13791.
62. Scarselli E., H. Ansuini, R. Cerino, R.M. Roccasecca, S. Acali, G. Filocamo, C. Traboni, A. Nicosia, R. Cortese and A. Vitelli. 2002. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 21: 5017-5025.
63. Shepard C.W., L. Finelli and M.J. Alter. 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5: 558-567.
64. Shin K., V.C. Fogg and B. Margolis. 2006. Tight junctions and cell polarity. Ann. Rev. Cell Dev. Biol. 22: 207-235.
65. Simmonds P., J. Bukh, C. Combet, G. Deleage, N. Enomoto, S. Feinstone, P. Halfon, G. Inchauspe, C. Kuiken, G. Maertens, et al. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42: 962-973 (Pubitemid 41401136)
66. Thomssen R., S. Bonk, C. Propfe, K.H. Heermann, H.G. Kochel and A. Uy. 1992. Association of hepatitis C virus in human sera with beta-lipoprotein. Med. Microbiol. Immunol. 181: 293-300.
67. Voisset C., N. Callens, E. Blanchard, A. Op De Beeck, J. Dubuisson and N. Vu-Dac. 2005. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J. Biol. Chem. 280: 7793-7799.
68. von Hahn T., B.D. Lindenbach, A. Boullier, O. Quehenberger, M. Paulson, C.M. Rice and J.A. McKeating. 2006. Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells. Hepatology 43: 932-942.
69. Wakita T., T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H. G. Krausslich, M. Mizokami, R. Bartenschlager and T.J. Liang. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nature Med. 11: 791-796. (Pubitemid 41021213)
70. Wolk B., B. Buchele, D. Moradpour and C.M. Rice. 2008. A dynamic view of hepatitis C virus replication complexes. J. Virol. 82: 10519-10531. (Pubitemid 352691191)
71. Ye J. 2007. Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus. PLoS Pathogen 3: e108. (Pubitemid 47359080)
72. Zheng A., F. Yuan, Y. Li, F. Zhu, P. Hou, J. Li, X. Song, M. Ding and H. Deng. 2007. Claudin-6 and Claudin-9 function as additional coreceptors for hepatitis C virus. J. Virol. 81: 12465-12471. (Pubitemid 350085860)